These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24965024)

  • 1. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone.
    Coelho-Filho OR; Shah RV; Neilan TG; Mitchell R; Moreno H; Kwong R; Jerosch-Herold M
    J Am Heart Assoc; 2014 Jun; 3(3):e000790. PubMed ID: 24965024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
    Coelho-Filho OR; Shah RV; Mitchell R; Neilan TG; Moreno H; Simonson B; Kwong R; Rosenzweig A; Das S; Jerosch-Herold M
    Circulation; 2013 Sep; 128(11):1225-33. PubMed ID: 23912910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical left ventricular myocardial remodeling in patients with Friedreich's ataxia: A cardiac MRI study.
    Takazaki KAG; Quinaglia T; Venancio TD; Martinez ARM; Shah RV; Neilan TG; Jerosch-Herold M; Coelho-Filho OR; França MC
    PLoS One; 2021; 16(3):e0246633. PubMed ID: 33770103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study.
    Coelho-Filho OR; Shah R; Lavagnoli CFR; Barros JC; Neilan TG; Murthy VL; de Oliveira PPM; Souza JRM; de Oliveira Severino ESB; de Souza Vilarinho KA; da Mota Silveira Filho L; Garcia J; Semigran MJ; Coelho OR; Jerosch-Herold M; Petrucci O
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):15-24. PubMed ID: 27437924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Simko F; Potácová A; Pelouch V; Paulis L; Matúsková J; Krajcírovicová K; Pechánová O; Adamcová M
    Physiol Res; 2007; 56 Suppl 2():S55-S62. PubMed ID: 17824806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
    Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.
    Kwiecinski J; Lennen RJ; Gray GA; Borthwick G; Boswell L; Baker AH; Newby DE; Dweck MR; Jansen MA
    J Cardiovasc Magn Reson; 2020 Aug; 22(1):57. PubMed ID: 32758255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction.
    McDiarmid AK; Swoboda PP; Erhayiem B; Bounford KA; Bijsterveld P; Tyndall K; Fent GJ; Garg P; Dobson LE; Musa TA; Foley JRJ; Witte KK; Kearney MT; Greenwood JP; Plein S
    J Am Heart Assoc; 2020 Jan; 9(1):e011521. PubMed ID: 31852424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats.
    Cezar MD; Damatto RL; Pagan LU; Lima AR; Martinez PF; Bonomo C; Rosa CM; Campos DH; Cicogna AC; Gomes MJ; Oliveira SA; Blotta DA; Okoshi MP; Okoshi K
    Cell Physiol Biochem; 2015; 36(4):1453-66. PubMed ID: 26160286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
    Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat.
    Leader CJ; Wilkins GT; Walker RJ
    PLoS One; 2021; 16(11):e0260554. PubMed ID: 34843581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary nitrite supplementation attenuates cardiac remodeling in l-NAME-induced hypertensive rats.
    Sonoda K; Ohtake K; Uchida H; Ito J; Uchida M; Natsume H; Tamada H; Kobayashi J
    Nitric Oxide; 2017 Jul; 67():1-9. PubMed ID: 28438687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy.
    Ocsan RJ; Lai YN; Prabhu KV; Hambly BD; McLachlan CS
    J Physiol Pharmacol; 2013 Dec; 64(6):727-36. PubMed ID: 24388887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.